Research Corporation Technologies

Total investments

28

Average round size

16M

Portfolio companies

18

Rounds per year

0.76

Lead investments

4

Follow on index

0.36

Exits

1

Stages of investment
Late Stage Venture
Areas of investment
BiotechnologyAnalyticsHealth CareHealth DiagnosticsMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

Research Corporation Technologies is the famous Corporate Investor, which was founded in 1987. The main office of represented Corporate Investor is situated in the Tucson. The venture was found in North America in United States.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Research Corporation Technologies, startups are often financed by California Technology Ventures, Ben Franklin Technology Partners of Southeastern Pennsylvania, William Harris Investors. The meaningful sponsors for the fund in investment in the same round are California Technology Ventures, BroadOak Capital Partners, Aphelion Capital. In the next rounds fund is usually obtained by Aphelion Capital, Themelios Ventures, Stanmore Medical Investments.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Therapeutics, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline Dispersol Technologies, Providence Medical Technology, Cylene Pharmaceuticals

The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2016. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2015. Speaking about the real fund results, this Corporate Investor is 27 percentage points more often commits exit comparing to other organizations.

Show more

Investments analytics

Analytics

Total investments
28
Lead investments
4
Exits
1
Rounds per year
0.76
Follow on index
0.36
Investments by industry
  • Biotechnology (20)
  • Health Care (14)
  • Pharmaceutical (10)
  • Medical (9)
  • Medical Device (9)
  • Show 13 more
Investments by region
  • United States (25)
  • United Kingdom (3)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
14
Group Appearance index
0.89
Avg. company exit year
16

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
OrthAlign 15 Mar 2010 Biotechnology, Health Care, Health Diagnostics, Medical Device, Medical, Navigation Early Stage Venture 5M United States, California
Pheon Therapeutics 21 May 2024 Biotechnology, Medical, Life Science, Therapeutics Early Stage Venture 120M England, London, United Kingdom
TimelyMD 15 Jul 2019 Software, Health Care, Hospital, Medical, Email Early Stage Venture 4M United States, Texas, Fort Worth

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.